PharmacoEconomics and Outcomes News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Semaglutide + metformin not cost effective vs empagliflozin + metformin for T2DM in Denmark
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 1, 2021 Category: Drugs & Pharmacology Source Type: news
Olaparib cost effective for in BRCA-mutated advanced ovarian carcinoma in Spain
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 1, 2021 Category: Drugs & Pharmacology Source Type: news
Additional MRI more effective for initial staging in pancreatic cancer than standard imaging and less costly
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 1, 2021 Category: Drugs & Pharmacology Source Type: news
TB screening + treatment of young asylum seekers arriving in Germany may be cost effective
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 1, 2021 Category: Drugs & Pharmacology Source Type: news
SGLT-2 inhibitors most cost effective for symptomatic and asymptomatic HFrEF
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 1, 2021 Category: Drugs & Pharmacology Source Type: news
WHO multi-dose vial policy for immunisation programme reduces wastage, saves costs in Egypt
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2021 Category: Drugs & Pharmacology Source Type: news
Discontinuing antidepressants: no QALY gain, no cost savings in the short term in the UK
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2021 Category: Drugs & Pharmacology Source Type: news
Statin treatment is highly cost effective in young adult men with LDL cholesterol ≥130 mg/dL
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2021 Category: Drugs & Pharmacology Source Type: news
Breast reduction surgery for symptomatic breast hypertrophy cost effective in Australia
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2021 Category: Drugs & Pharmacology Source Type: news
Year-round influenza vaccination of pregnant women, young infants saves costs in Hong Kong
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2021 Category: Drugs & Pharmacology Source Type: news
TNF- α inhibitor persistence less costly in inflammatory arthritis
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2021 Category: Drugs & Pharmacology Source Type: news
Burden of spinal muscular atrophy high, varies according to disease type and motor function
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2021 Category: Drugs & Pharmacology Source Type: news
Invasive meningococcal disease uncommon but a high economic burden for Spain
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2021 Category: Drugs & Pharmacology Source Type: news
Latest NICE draft guidance does not recommend elusulfase alfa for rare disorder
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2021 Category: Drugs & Pharmacology Source Type: news
New NICE guideline for diagnosis and management of myalgic encephalopathy/chronic fatigue syndrome
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2021 Category: Drugs & Pharmacology Source Type: news